SION

2.8254.88%
GH

Greg Hurlbut

Co-Founder & Senior VP of Discovery Research

Dr. Greg Hurlbut, Ph.D., is Co-Founder and Senior Vice President of Discovery Research of Sionna Therapeutics, Inc. He was the Head of Protein Conformational Diseases and Rare Pulmonary Diseases Research at Sanofi Genzyme. He was the Principal Investigator for 32 million in grant funding from the Cystic Fibrosis Foundation Therapeutics Development Initiative to support CF drug discovery and preclinical development. He also served as an adjunct faculty member in the Department of Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School. He received his Ph.D. in cell and molecular biology from Université Paris XI (Paris-Saclay), where he graduated summa cum laude for research performed at Massachusetts General Hospital and Harvard Medical School. He received a B.S. in biology from the University of Massachusetts, Amherst.

Positions